TETRALOGIC PHARMACEUTICALS CORP Common Stock
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TLOG and buy or sell other stocks, ETFs, and their options commission-free!About TLOG
TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel small molecule therapeutics in oncology and infectious diseases. Its products include Birinapant and SHAPE.
CEOJ. Kevin Buchi, MBA, CPA
CEOJ. Kevin Buchi, MBA, CPA
Employees11
Employees11
HeadquartersMalvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded2001
Founded2001
Employees11
Employees11
TLOG Key Statistics
Market cap4.89K
Market cap4.89K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.001
52 Week high$0.001
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
TETRALOGIC PHARMACEUTICALS CORP Common Stock(TLOG) stock is priced at $0.00, giving the company a market capitalization of 4.89K.
On 2026-07-25, TETRALOGIC PHARMACEUTICALS CORP Common Stock(TLOG) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for TETRALOGIC PHARMACEUTICALS CORP Common Stock(TLOG) stock has reached 0.
Over the past 52 weeks, TETRALOGIC PHARMACEUTICALS CORP Common Stock(TLOG) stock has traded between a high of $0.00 and a low of $0.00.
Over the past 52 weeks, TETRALOGIC PHARMACEUTICALS CORP Common Stock(TLOG) stock has traded between a high of $0.00 and a low of $0.00.